Access cutting-edge viral infections treatment through this clinical trial at a research site in Palo Alto. Study-provided care at no cost to qualified participants.
Access viral infections specialists in Palo Alto at no cost
This study follows strict safety protocols and ethical guidelines
All study-related viral infections treatment provided free
The primary purpose of this phase I/II study is to evaluate whether partially matched, ≥2/6 HLA-matched, viral specific T cells have efficacy against adenovirus, CMV, and EBV, in subjects who have previously received any type of allogeneic HCT or solid organ transplant (SOT), or have compromised immunity. Reconstitution of anti-viral immunity by donor-derived cytotoxic T lymphocytes has shown promise in preventing and treating infections with adenovirus, CMV, and EBV. However, the weeks taken to
Sponsor: Jessie L. Alexander
Check if you qualify for this viral infections clinical trial in Palo Alto, CA
If you're searching for viral infections treatment options in Palo Alto, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Palo Alto research site is actively enrolling participants for this clinical trial. You'll receive care from experienced viral infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.